These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15792266)

  • 21. [Perspectives in the treatments of poisonings by organophosphorus insecticides and warfare nerve agents].
    Sogorb-Sánchez MA; Vilanova-Gisbert E; Carrera-González V
    Rev Neurol; 2004 Oct 16-31; 39(8):739-47. PubMed ID: 15514903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological and clinical aspects of combat anticholinesterase poisoning.
    Weinbroum AA
    Br Med Bull; 2004; 72():119-33. PubMed ID: 15845747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridostigmine used as a nerve agent pretreatment under wartime conditions.
    Keeler JR; Hurst CG; Dunn MA
    JAMA; 1991 Aug; 266(5):693-5. PubMed ID: 2072481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The acute treatment of nerve agent exposure.
    Cannard K
    J Neurol Sci; 2006 Nov; 249(1):86-94. PubMed ID: 16945386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
    Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
    Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
    Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central anticholinergics to treat nerve-agent poisoning.
    Janowsky DS
    Lancet; 2002 Jan; 359(9302):265-6. PubMed ID: 11812600
    [No Abstract]   [Full Text] [Related]  

  • 28. Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis.
    Moss JI
    Med Hypotheses; 2012 Aug; 79(2):283-4. PubMed ID: 22632735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioscavengers for the protection of humans against organophosphate toxicity.
    Doctor BP; Saxena A
    Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning.
    DeLorenzo RA
    JEMS; 2001 Jun; 26(6):48-57. PubMed ID: 11409202
    [No Abstract]   [Full Text] [Related]  

  • 31. Complex view on poisoning with nerve agents and organophosphates.
    Bajgar J
    Acta Medica (Hradec Kralove); 2005; 48(1):3-21. PubMed ID: 16080378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosporus insecticide and nerve agent poisonings.
    Sogorb MA; Vilanova E; Carrera V
    Toxicol Lett; 2004 Jun; 151(1):219-33. PubMed ID: 15177657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaesthesia and critical care considerations in nerve agent warfare trauma casualties.
    Weinbroum AA; Rudick V; Paret G; Kluger Y; Ben Abraham R
    Resuscitation; 2000 Oct; 47(2):113-23. PubMed ID: 11008149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nerve paralytic agents--the greatest threat for mass poisoning during chemical warfare or terrorist attacks].
    Kassa J
    Cas Lek Cesk; 2001 Dec; 140(24):745-51. PubMed ID: 14655276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of oral pyridostigmine bromide nerve agent prophylaxis on return of twitch height in persons receiving succinylcholine.
    Pellegrini JE; Baker AB; Fontenot DJ; Cardenas AF
    Mil Med; 2000 Apr; 165(4):252-5. PubMed ID: 10802993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the value of huperzine as pretreatment of organophosphate poisoning.
    Lallement G; Baille V; Baubichon D; Carpentier P; Collombet JM; Filliat P; Foquin A; Four E; Masqueliez C; Testylier G; Tonduli L; Dorandeu F
    Neurotoxicology; 2002 May; 23(1):1-5. PubMed ID: 12164543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical weapons: antidotes. View about the real means, perspectives].
    Ricordel I; Meunier J
    Ann Pharm Fr; 2000 Jan; 58(1):5-12. PubMed ID: 10669805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of antidotes: problems and strategies.
    Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P
    Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
    Krejcova-Kunesova G; Bartosova L; Kuca K
    Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
    Worek F; Szinicz L; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.